Brief Communication abstract


Nature Genetics 39, 1437 - 1439 (2007)
Published online: 18 November 2007 | doi:10.1038/ng.2007.23

Cystatin C modulates cerebral bold beta-amyloidosis

Stephan A Kaeser1, Martin C Herzig1, Janaky Coomaraswamy1, Ellen Kilger1, Maj-Linda Selenica2, David T Winkler3, Matthias Staufenbiel4, Efrat Levy5, Anders Grubb2 & Mathias Jucker1

Top

The CST3 Thr25 allele of CST3, which encodes cystatin C, leads to reduced cystatin C secretion and conveys susceptibility to Alzheimer's disease. Here we show that overexpression of human cystatin C in brains of APP-transgenic mice reduces cerebral amyloid-beta deposition and that cystatin C binds amyloid-beta and inhibits its fibril formation. Our results suggest that cystatin C concentrations modulate cerebral amyloidosis risk and provide an opportunity for genetic risk assessment and therapeutic interventions.

Top
  1. Department of Cellular Neurology, Hertie-Institute for Clinical Brain Research, University of Tübingen, Otfried-Müller Strasse 27, D-72076 Tübingen, Germany.
  2. Department of Clinical Chemistry, Lund University Hospital, 22185 Lund, Sweden.
  3. Department of Neuropathology, Institute of Pathology, University of Basel, CH-4003 Basel, Switzerland.
  4. Novartis Institutes for Biomedical Research Basel, Nervous System, CH-4002 Basel, Switzerland.
  5. Departments of Psychiatry and Pharmacology, New York University School of Medicine, New York, New York 10016, USA and Nathan Kline Institute, Orangeburg, New York 10962, USA.

Correspondence to: Mathias Jucker1 e-mail: mathias.jucker@uni-tuebingen.de



MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

An animal model of vascular amyloidosis

Nature Neuroscience News and Views (01 Sep 2004)

Sand in the sheets

Nature Medicine News and Views (01 Feb 1995)

See all 3 matches for News And Views

Extra navigation

Subscribe to Nature Genetics

Subscribe

Open Innovation Challenges

naturejobs

ADVERTISEMENT